NCT04864353Completed
Internet-delivered Intervention Targeting Residual Cognitive Symptoms After Major Depressive Disorder
A Guided Internet-delivered Intervention for Adults With Residual Cognitive Symptoms After Major Depressive Disorder: Study Protocol for a Randomized Controlled Trial Investigating Clinical Effects
Source: ClinicalTrials.gov · Last updated 12 Mar 2025
Brief summary (registry, in English)
Background: Cognitive impairment and difficulties are frequently observed in individuals suffering from major depressive disorder. These impairments and difficulties can persist into remission as residual cognitive symptoms. Consequently affecting daily life functioning and quality of life for those affected. Few scalable interventions have targeted these symptoms and measured long-term clinical effects such as depression relapse.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 44 (actual)
- First submitted
- 21 Apr 2021
- Start date
- 26 Apr 2021
- Primary completion date
- 31 Oct 2023
- Lead sponsor
- Haukeland University Hospital
- Diseases
- Depression
- NCT number
- NCT04864353
What you commit to
- Study type: Interventional
- Participants enrolled: 44
- From 26 Apr 2021 to the primary completion date, 31 Oct 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Neurological conditions or damage (e.g. autism, cerebral haemorrhage, and brain tumour)
- Bipolar disorder
Other
- Self-reported substance abuse
- Psychosis.
Who the study is looking for
- Previously received treatment for major depressive disorder in primary or secondary healthcare services
- Reporting a history of major depressive disorder symptoms assess using the MINI. few or minor depression symptomss (\< 12 MADRS)
- Not meeting criteria for major depressive disorder measured by the MINI)
- Self-reporting residual cognitive symptoms that affects daily functioning (assessed by clinical psychologist)
- No changes in anti-depressant medication under the study period
- Age between 18 and 65 years
- Read and write Norwegian
- Internet and telephone access.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Haukeland University Hospital Coordinator of this site? Confirm its status | Bergen | Norway | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.